Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : American Presidential Politics and foreign affairs -- Ignore unavailable to you. Want to Upgrade?

To: TimF who wrote (28099)	4/27/2008 12:24:41 PM
From: DuckTapeSunroof	Read Replies (1) \| Respond to of 71588

I, (of course), believe the only important metrics in this area (defined as "national health care outcomes), are the fully objective ones such as average length of life in a nation's population, percentage rate of infant or childhood death, birth weight averages, prevalence of diseases, etc., etc., etc. ANY 'study' that attempted to 'massage' it's final figures by 'correcting' for wealth differentials is a study where I would want to IGNORE the headline 'results' (that used the 'wealth correction factor'), and I'd look BEYOND that and back to the unmanipulated raw statistical data on ACTUAL health outcomes. Of course... as I have already indicated, I believe it is fair to, as much as possible, try to compare 'apples to apples', and restrict comparisons of our nation's actual health care results to those of SIMILAR (i.e, our peer group of other 'most developed' and Democratic nations because --- obviously --- we have very little in common with say, Zimbabwe or Melanesia... :-) Regardless though... there remains no doubt whatsoever that the US health care system is the single MOST EXPENSIVE in the world... or that, (compared to a grab bad of peer group 'most developed' wealthy industrial Democratic nations such as the ones I referred to, Switzerland, Taiwan, Germany, Japan... or even France, U.K. or Canada), we receive lesser 'posititive results' from our comparatively much higher level of national expenditure then most do. Or that our businesses are increasing suffering from expense differentials that adversely impact their ability to compete against foreign rivals in world export markets.... In short: we PAY far too much... and receive lesser value for marginal health care cost then many others do.